1. The appointment of Elizabeth McKee Anderson was made by the Board on the recommendation of the Nominations & Corporate Governance Committee. The Committee conducted an extensive search and selection process for this appointment, using an external search firm, which is a signatory of the Voluntary Code of Conduct for Executive Search Firms. The external search firm provided a diverse list of candidates who were approached, evaluated and interviewed, against an agreed set of criteria aligned to the Board's target skills matrix.
| |
2. The Board has determined that Elizabeth McKee Anderson is an independent Non-Executive Director in accordance with the UK Corporate Governance Code.
| |
3. Ms McKee Anderson will receive the standard basic fee for a Non-Executive Director of £95,000 per annum. (Ms McKee Anderson will be required to build towards a share ownership requirement of GSK shares in accordance with the Company's shareholder approved Non-Executive remuneration policy).
| |
4. Ms McKee Anderson has also been appointed a member of the Audit & Risk and Remuneration committees.
| |
5. Ms McKee Anderson does not have a service contract. She has a letter of appointment which may be viewed by contacting the Company Secretary at the Company's registered office.
| |
6. There are no further disclosures to be made in respect of Ms McKee Anderson's appointment under Listing Rule 9.6.13R.
| |
7. As of 1 September 2022 the Board of GSK will comprise:
|
Sir Jonathan Symonds
|
Non-Executive Chair
|
Emma Walmsley
|
Chief Executive Officer
|
Iain Mackay
|
Chief Financial Officer
|
Charles Bancroft
|
Senior Independent Non-Executive Director
|
Elizabeth McKee Anderson
|
Independent Non-Executive Director
|
Dr Hal Barron
|
Non-Executive Director
|
Dr Anne Beal
|
Independent Non-Executive Director
|
Dr Hal Dietz
|
Independent Non-Executive Director
|
Dr Jesse Goodman
|
Independent Non-Executive Director
|
Dr Laurie Glimcher*
|
Independent Non-Executive Director
|
Urs Rohner
|
Independent Non-Executive Director
|
Dr Vishal Sikka
|
Independent Non-Executive Director
|
GSK enquiries
| |||
Media:
|
Simon Moore
|
+44 (0) 20 8047 5502
|
(London)
|
Alison Hunt
|
+1 202 603 5003
|
(Washington DC)
| |
Investor Relations:
|
Nick Stone
|
+44 (0) 7717 618834
|
(London)
|
James Dodwell
|
+44 (0) 20 8047 2406
|
(London)
| |
Mick Readey
|
+44 (0) 7990 339653
|
(London)
| |
Josh Williams
|
+44 (0) 7385 415719
|
(London)
| |
Jeff McLaughlin
|
+1 215 751 7002
|
(Philadelphia)
|
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
GSK plc published this content on 24 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 August 2022 11:07:02 UTC.